Appropriate pharmacology should be initiated before, during and following percutaneous coronary intervention in patients with left ventricular dysfunction or heart failure

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 23, Iss. 6, 2007-06 ,pp. : 16-20

Adis International

Access to resources Recommend Favorite

The treatment of chronic heart failure due to left ventricular systolic dysfunction

By Gardner R S   McDonagh T A  

Clinical Medicine, Vol. 4, Iss. 1, 2004-01 ,pp. : 18-22

Royal College Of Physicians

Access to resources Recommend Favorite

The Influence of Complete Coronary Revascularization on Long-term Outcomes in Patients with Multivessel Coronary Heart Disease Undergoing Successful Percutaneous Coronary Intervention

By Yang HH   Chen Y   Gao CY  

The Journal of International Medical Research, Vol. 38, Iss. 3, 2010-06 ,pp. : 1106-1112

Field House Publishing

Access to resources Recommend Favorite

Effect of Dronedarone on Exercise Capacity and Cardiac Function in Patients With Severe Left Ventricular Dysfunction and Compensated Stable Heart Failure

By Levine T.   Giles Thomas   Radzik David   Ghali Jalal  

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 5-6, 2010-12 ,pp. : 449-458

Springer Publishing Company

Access to resources Recommend Favorite

Diuretic Therapy in Elderly Heart Failure Patients With and Without Left Ventricular Systolic Dysfunction

By van Kraaij D.J.W.  

Drugs & Aging, Vol. 16, Iss. 4, 2000-04 ,pp. : 289-300

Adis International

Access to resources Recommend Favorite